iRhythm Technologies, Inc.Pembelian
$IRTC Ready to make a run?
Diupdate
I've been watching this name for awhile now. I think it has been held back by a bad market and since it's a medical devise company, COVID & elective surgeries may have played a roll. I'm doing an early entry here with a very tight stop. I like how it has moved above the 30 Week MA and both the 10 Week, 30 Week and 65 Day MA's are all pointing up. I was triggered in on a 5 min chart. As I said, very early entry and presents a higher risk as it's still basing. Maybe one for your watch list. Ideas, not investing / trading advice.
From earningswhispers.com
Nov 4 2021
Irhythm Technologies (IRTC) reported a 3rd Quarter September 2021 loss of $0.81 per share on revenue of $85.4 million. The consensus estimate was a loss of $1.09 per share on revenue of $83.6 million. Revenue grew 18.7% on a year-over-year basis.
What they offer:
Single-use
Cardiac Monitoring
The Zio service is a complete ambulatory cardiac monitoring solution built with the patient in mind — and reinforced with clinical evidence.
From earningswhispers.com
Nov 4 2021
Irhythm Technologies (IRTC) reported a 3rd Quarter September 2021 loss of $0.81 per share on revenue of $85.4 million. The consensus estimate was a loss of $1.09 per share on revenue of $83.6 million. Revenue grew 18.7% on a year-over-year basis.
What they offer:
Single-use
Cardiac Monitoring
The Zio service is a complete ambulatory cardiac monitoring solution built with the patient in mind — and reinforced with clinical evidence.
Trading ditutup: stop tercapai
Well, that didn't work as planned. Closed at 99.50 as it simply dropped below my stop. Back on the watch list.
Ideas I publish are my own. They are not meant to be investment / trading advice. You are encouraged to do your own due diligence.
I may or may not take any trade published and I am under no obligation to post any action or update to any idea.
I may or may not take any trade published and I am under no obligation to post any action or update to any idea.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.